Cellcom Israel Ltd. — Director's Dealing 2025

Aug 13, 2025

CELLCOM ISRAEL LTD.

CELLCOM ISRAEL LTD.

Registration Number: 511930125

To: Israel Securities Authority To: Tel Aviv Stock Exchange Ltd. Form Number: T076 (Public) Sent via MAGNA: 13/08/2025 Israel Securities Authority Email: www.isa.gov.il Tel Aviv Stock Exchange Email: www.tase.co.il Reference: 2025-01-060325

Immediate Report on Changes in Holdings of Interested Parties and Senior Officers

Regulation 33(b) of the Securities Regulations (Periodic and Immediate Reports), 1970

Note: This form is intended for reporting changes in holdings of securities of the reporting corporation only. For reporting changes in holdings of securities of a subsidiary of the reporting corporation, if its activity is material to the activity of the reporting corporation, use Form T121.

1

Name of corporation/Last name and first name of holder: Gadi Attias

Name of corporation/Last name and first name of holder in English as registered with the Companies Registrar or in passport: GADI ATTIAS

Type of identification number: ID number

Holder's identification number: 032217085

Type of holder: Senior officer who is not a CEO or director and is not an interested party by virtue of holdings

Does the hedge fund have the right to appoint a director or representative to the company's board?

Is the holder acting as a representative for the purpose of reporting on behalf of several shareholders holding together securities of the corporation? No

Name of controlling shareholder in the interested party: Not relevant

Identification number of controlling shareholder in the interested party:

Citizenship/ Country of incorporation or registration: Private individual with Israeli citizenship

Country of citizenship / incorporation or registration:

Security number on the stock exchange: 1106038

Name and type of security: CELLCOM ISRAEL LTD. Warrant 2007

Nature of change: Increase Due to private placement

Note: Purchase or sale of shares on the stock exchange by way of a matched transaction, as defined in the third part of the stock exchange regulations, will be classified as an offexchange transaction, with disclosure in the free text field that the transaction was carried out in this way.

Is this a change in a single transaction or multiple transactions (cumulative change): Single transaction

Date of change: 13/08/2025

Transaction rate: 0.000 Currency: agorot

Are these dormant shares or securities convertible into dormant shares: No

Balance (in number of securities) in the last report: 0 Holding percentage of total securities of the same type in the last report: % 0

Change in quantity of securities: +250,000

Current balance (in number of securities): 250,000 Current holding percentage of total securities of the same type: % 4.49

Holding percentage after the change: In capital: % 0.00 In voting rights: % 0.00

Explanation: The holding percentage after the change does not refer to convertible securities.

Holding percentage after the change on a fully diluted basis: In capital: % 0.14 In voting rights: % 0.14

Note number:

2

Name of corporation/Last name and first name of holder: Avi Grinman

Name of corporation/Last name and first name of holder in English as registered with the Companies Registrar or in passport: AVRAHAM GRINMAN

Type of identification number: ID number

Holder's identification number: 028498558

Type of holder: Senior officer who is not a CEO or director and is not an interested party by virtue of holdings

Does the hedge fund have the right to appoint a director or representative to the company's board?

Is the holder acting as a representative for the purpose of reporting on behalf of several shareholders holding together securities of the corporation? No

Name of controlling shareholder in the interested party: Not relevant

Identification number of controlling shareholder in the interested party:

Citizenship/ Country of incorporation or registration: Private individual with Israeli citizenship

Country of citizenship / incorporation or registration:

Security number on the stock exchange: 1106038

Name and type of security: CELLCOM ISRAEL LTD. Warrant 2007

Nature of change: Increase Due to private placement

Note: Purchase or sale of shares on the stock exchange by way of a matched transaction, as defined in the third part of the stock exchange regulations, will be classified as an offexchange transaction, with disclosure in the free text field that the transaction was carried out in this way.

Is this a change in a single transaction or multiple transactions (cumulative change): Single transaction

Date of change: 13/08/2025

Transaction rate: 000 Currency: agorot

Are these dormant shares or securities convertible into dormant shares: No

Balance (in number of securities) in the last report: 0 Holding percentage of total securities of the same type in the last report: % 0

Change in quantity of securities: +181,445

Current balance (in number of securities): 181,445 Current holding percentage of total securities of the same type: % 3.16

Holding percentage after the change: In capital: % 0.00 In voting rights: % 0.00

Explanation: The holding percentage after the change does not refer to convertible securities.

Holding percentage after the change on a fully diluted basis: In capital: % 0.10 In voting rights: % 0.10

Note number: 1

3

Name of corporation/Last name and first name of holder: Sivan Shushan Lisha

Name of corporation/Last name and first name of holder in English as registered with the Companies Registrar or in passport: SIVAN SHUSHAN LISHA

Type of identification number: ID number

Holder's identification number: 066038159

Type of holder: Senior officer who is not a CEO or director and is not an interested party by virtue of holdings

Does the hedge fund have the right to appoint a director or representative to the company's board?

Is the holder acting as a representative for the purpose of reporting on behalf of several shareholders holding together securities of the corporation? No

Name of controlling shareholder in the interested party: Not relevant

Identification number of controlling shareholder in the interested party:

Citizenship/ Country of incorporation or registration: Private individual with Israeli citizenship

Country of citizenship / incorporation or registration:

Security number on the stock exchange: 1106038

Name and type of security: CELLCOM ISRAEL LTD. Warrant 2007

Nature of change: Increase Due to private placement

Note: Purchase or sale of shares on the stock exchange by way of a matched transaction, as defined in the third part of the stock exchange regulations, will be classified as an offexchange transaction, with disclosure in the free text field that the transaction was carried out in this way.

Is this a change in a single transaction or multiple transactions (cumulative change): Single transaction

Date of change: 13/08/2025

Transaction rate: 0.000 Currency: agorot

Are these dormant shares or securities convertible into dormant shares: No

Balance (in number of securities) in the last report: 197,599 Holding percentage of total securities of the same type in the last report: % 3.44

Change in quantity of securities: +181,445

Current balance (in number of securities): 379,044 Current holding percentage of total securities of the same type: % 6.39

Holding percentage after the change: In capital: % 0.00 In voting rights: % 0.00

Explanation: The holding percentage after the change does not refer to convertible securities.

Holding percentage after the change on a fully diluted basis: In capital: % 0.22 In voting rights: % 0.22

Note number:

4

Name of corporation/Last name and first name of holder: Larisa Cohen

Name of corporation/Last name and first name of holder in English as registered with the Companies Registrar or in passport: LARISA COHEN

Type of identification number: ID number

Holder's identification number: 034211235

Type of holder: Senior officer who is not a CEO or director and is not an interested party by virtue of holdings

Does the hedge fund have the right to appoint a director or representative to the company's board?

Is the holder acting as a representative for the purpose of reporting on behalf of several shareholders holding together securities of the corporation? No

Name of controlling shareholder in the interested party: Not relevant.

Identification number of controlling shareholder in the interested party:

Citizenship/ Country of incorporation or registration: Private individual with Israeli citizenship

Country of citizenship / incorporation or registration:

Security number on the stock exchange: 1106038

Name and type of security: CELLCOM ISRAEL LTD. Warrant 2007

Nature of change: Increase Due to private placement

Note: Purchase or sale of shares on the stock exchange by way of a matched transaction, as defined in the third part of the stock exchange regulations, will be classified as an offexchange transaction, with disclosure in the free text field that the transaction was carried out in this way.

Is this a change in a single transaction or multiple transactions (cumulative change): Single transaction

Date of change: 13/08/2025

Transaction rate: 0.000 Currency: agorot

Are these dormant shares or securities convertible into dormant shares: No

Balance (in number of securities) in the last report: 0 Holding percentage of total securities of the same type in the last report: % 0

Change in quantity of securities: +181,445

Current balance (in number of securities): 181,445 Current holding percentage of total securities of the same type: % 2.97

Holding percentage after the change: In capital: % 0.00 In voting rights: % 0.00

Explanation: The holding percentage after the change does not refer to convertible securities.

Holding percentage after the change on a fully diluted basis: In capital: % 0.10 In voting rights: % 0.10

Note number: 1

Note: If the value "increase due to forced purchase of loaned securities" or "decrease due to forced sale of loaned securities" is selected, then loaned securities that were not returned to the lender and thus the lending action became a forced purchase and the lending action a forced sale.

No.

Note

1

The allocation of the warrants to the above-mentioned officer is in continuation of the outline for employees dated February 9, 2025 (Reference No. 2025-01- 009579). The warrants will vest in four equal tranches at the end of one, two, first, three, and four years from August 13, 2025. The exercise price for the second, third, and fourth tranches will be 29.36 NIS per share (for more details see section 2.5.2 of the outline). Regarding the number of shares resulting from the exercise of the warrants - the number of shares actually allocated following the exercise of the warrants as stated will be in an amount that reflects the monetary benefit value embedded in the exercise of the warrants at the time of exercise (Net Exercise).

1. Was the entire consideration paid at the time of the change? Yes

If not all the consideration was paid at the time of the change, please specify the date of completion of the payment:

1. If the change is by way of signing a loan agreement, please specify details regarding the manner of ending the loan:

Explanation: Please specify the holding percentages taking into account all securities held by the interested party.

• 1. The date and time the corporation first became aware of the event or matter: 13/08/2025 at 12:30
• 1. Details of the actions that caused the change:

Details of the authorized signatories on behalf of the corporation:

No.	Name of Signatory	Position
1	Larisa Cohen	Other: VP Legal Counsel and Regulation

Explanation: According to Regulation 5 of the Periodic and Immediate Reports Regulations (1970), a report submitted under these regulations shall be signed by those authorized to sign on behalf of the corporation. Staff position on the matter can be found on the Authority's website: Click here.

Previous reference numbers of documents on the subject (the mention does not constitute inclusion by reference):

Securities of the corporation are listed for trading on the Tel Aviv Stock Exchange

Form structure update date: 04/02/2025

Short name:

Address: Hagavish 10, Netanya 4250708 Phone: 052-9989595, Fax: 09-8607986

Email: cellcom\_sec@cellcom.co.il

Previous names of the reporting entity:

Name of electronic reporter: Cohen Larisa Position: VP Legal Counsel and Company Secretary Employer company name:

Address: Hagavish 10, Netanya 4250708 Phone: 052-9989595, Fax: 09-8607986 Email: larisaco@cellcom.co.il